A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States-Reference-Cited by-同舟云学术

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States

Published:2023-10 Issue:44 Volume:41 Page:6456-6467
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Wallace Megan^ORCID,Rosenblum Hannah G.,Moulia Danielle L.,Broder Karen R.,Shimabukuro Tom T.,Taylor Christopher A.,Havers Fiona P.,Meyer Sarah A.,Dooling Kathleen,Oliver Sara E.,Hadler Stephen C.,Gargano Julia W.

Funder

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference65 articles.

1. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) GRADE (Grading of Recommendations, Assessment, Development and Evaluation); 2019 [cited 2023 January 4]; Available from: https://www.cdc.gov/vaccines/acip/recs/index.html.

2. Fink D. Emergency use authorization: overview and considerations for COVID-19 vaccines; 2020 [cited 2023 January 19]; Available from: https://www.fda.gov/media/144329/download.

3. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe;Rosenblum;Lancet Infect Dis,2022

4. Centers for Disease Control and Prevention. Ensuring COVID-19 vaccine safety in the US; 2022 [cited 2023 January 4]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html.

5. Lee GM. COVID-19 Vaccine Safety Technical (VaST) Subgroup; 2021 [cited 2023 January 11]; Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-01/05-COVID-Lee-intro.pdf.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea;Osong Public Health and Research Perspectives;2024-08-31

2. mRNA Technology and Mucosal Immunization;Vaccines;2024-06-17

3. Development of COVID-19 vaccine policy — United States, 2020–2023;Vaccine;2023-12